Profile data is unavailable for this security.
About the company
The Biotech Growth Trust PLC is a United Kingdom-based investment trust. The Company's investment objective is to seek capital appreciation through investment in the biotechnology industry across the world. It invests in a diversified portfolio of shares and related securities in biotechnology companies. The Company invests approximately 10% in aggregate of the value of its gross assets in other closed-ended investment companies, including investment trusts listed on the London Stock Exchange. The Company invests approximately 15% of the value of its gross assets in any one individual stock at the time of acquisition. Its portfolio of investments across various countries includes Netherlands, the United States of America, Canada, and China. The Company’s alternative investment fund manager is Frostrow Capital LLP.
- Revenue in GBP (TTM)79.73m
- Net income in GBP74.60m
- Incorporated1997
- Employees0.00
- LocationThe Biotech Growth Trust PLC25 Southampton BuildingsLONDON WC2A 1ALUnited KingdomGBR
- Phone+44 20 3008 4910Fax+44 20 3043 8889
- Websitehttp://www.biotechgt.com/
Profile
| Management group(s) | OrbiMed Advisor LLC |
|---|---|
| AIC sector | Biotechnology & Healthcare |
| ISIN | GB0000385517 |
| Launch date | 23 Jun 1997 |
| Share type | Ordinary Share |
| Structure | Investment Trust |
| Base currency | GBP |
Objective
The Company seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.
Managed by
| Josh Golomb, Geoffrey C. Hsu |
|---|
Management & contract fees
AIFM receives a periodic fee equal to 0.30% p.a. of the market capitalisation up to GBP500m, 0.20% above GBP 500m to GBP 1bn and 0.10% over GBP 1bn. The Investment Manager receives a fee equal to 0.65% p.a. of the net assets. The Agreement may be terminated with not less than 12 months notice.
Peer analysis
| Company | Revenue (TTM) | Net income (TTM) |
|---|---|---|
| CT Private Equity Trust PLC | 24.80m | 7.62m |
| Baillie Gifford European Growth Trst PLC | 28.58m | 25.14m |
| Castelnau Group Ltd | 105.36m | 93.31m |
| Henderson International Income Trust PLC | 18.14m | 12.76m |
| Fintel PLC | 68.90m | 5.90m |
| abrdn Asian Income Fund Limited | 53.77m | 46.51m |
| Nippon Active Value Fund PLC | 65.77m | 59.10m |
| Biotech Growth Trust PLC | 79.73m | 74.60m |
| CT UK Capital and Income Invst Trust PLC | 45.06m | 41.17m |
| Scottish Oriental Smaller Co's Trust PLC | 53.44m | 40.62m |
| Fidelity Asian Values PLC | 6.02m | -5.81m |
| Baillie Gifford Shin Nippon PLC | -54.34m | -59.94m |
| Sherborne Investors (Guernsey) C Ltd | -113.51m | -116.46m |
| Invesco Bond Income Plus Ltd | 42.04m | 37.12m |
| Mortgage Advice Bureau (Holdings) PLC | 245.92m | 10.74m |
| Lowland Investment Company P L C | 33.31m | 28.66m |
Institutional shareholders
| Holder | Shares | % Held |
|---|---|---|
| Border to Coast Pensions Partnership Ltd.as of 31 Mar 2024 | 1.99m | 6.15% |
| Rathbones Investment Management Ltd.as of 31 Mar 2024 | 1.82m | 5.63% |
| Brewin Dolphin Ltd.as of 31 Mar 2024 | 1.78m | 5.51% |
| Hargreaves Lansdown Asset Management Ltd.as of 01 Jul 2024 | 1.36m | 4.20% |
| West Yorkshire Pension Fundas of 01 Jul 2024 | 1.07m | 3.31% |
| Columbia Threadneedle Asset Managers Ltd.as of 01 Jul 2024 | 693.73k | 2.15% |
| Close Asset Management Ltd.as of 01 Jul 2024 | 511.00k | 1.58% |
| Legal & General Investment Management Ltd.as of 01 Jul 2024 | 485.43k | 1.50% |
| Evelyn Partners Investment Management LLPas of 01 Jul 2024 | 459.00k | 1.42% |
| BlackRock Investment Management (UK) Ltd.as of 01 Jul 2024 | 404.39k | 1.25% |
